Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 24SevenOffice 247 May 27, 2022 11.45 +1.33   
 2cureX 2CUREX May 27, 2022 11.56 +3.77   
 4C Group AB 4C May 27, 2022 36.20 0.00   
 AAC Clyde Space AAC May 27, 2022 1.75 -0.74   
 AAK AAK May 27, 2022 167.15 +2.01   
 ABB ABB May 27, 2022 302.20 +2.82   
 Abelco Investment Group ABIG May 27, 2022 0.09 -1.12   
 Abera Bioscience ABERA May 27, 2022 8.61 +5.39   
 Abliva ABLI May 27, 2022 0.42 +3.28   
 Absolent Air Care Group ABSO May 27, 2022 380.00 +4.11   
 Absolicon ABSL May 27, 2022 114.50 +3.15   
 AcadeMedia ACAD May 27, 2022 49.02 +5.15   
 Acarix ACARIX May 27, 2022 0.54 -0.55   
 Acast ACAST May 27, 2022 15.34 +6.31   
 Acconeer ACCON May 27, 2022 52.80 +6.24   
 Acosense ACOS May 27, 2022 0.61 +13.86   
 AcouSort ACOU May 27, 2022 16.00 -2.08   
 ACQ Bure ACQSPAC May 27, 2022 94.00 +0.11   
 Acrinova A ACRIA May 27, 2022 12.80 -4.12   
 Acrinova B ACRIB May 27, 2022 10.00 -1.96   
 ACROUD ACROUD May 27, 2022 2.12 -1.40   
 Actic Group ATIC May 27, 2022 9.22 +2.44   
 Active Biotech ACTI May 27, 2022 1.12 +2.00   
 AcuCort ACUC May 27, 2022 2.30 0.00   
 Acuvi AB ACUVI May 27, 2022 35.80 +3.77   
 AdderaCare ADDERA May 27, 2022 3.10 +2.31   
 AddLife B ALIFB May 27, 2022 245.60 +5.59   
 Addnode Group B ANODB May 27, 2022 105.70 +3.93   
 Addtech B ADDTB May 27, 2022 162.60 +6.00   
 ADDvise Group A ADDVA May 27, 2022 6.96 +1.16   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+